Replies to post #279733 on Amarin Corp Plc (AMRN)

[Toanoman]

JL If a patient taking statins presents stable TG above 150 and the doc writes an off=label script for generic V, what will the patient get when pharmacy checks with patients drug plan and fills the Rx?
It would be sad if the script was filled with GL which wouldn't provide the CVD benefit of V.

Thanks

[ilovetech]

JL, yes, I remember the complaints. Yes, I agree that GL sales have been driven by the plans. As a novel drug for a small indication, I agree, JT did a poor job to differentiate Vascepa from Lovaza. Nonetheless, nearly 21 months have passed since TLD, and another 6 months, since winning the new indication. Doctors should understand the di

stinction between the two drugs by now. Unlike before, I believe, Doctors are far more inclined to add DAW today.

My theory is that we have a residual cadre of docs who continue with their bad habits of writing for GL out of ignorance. The former I believe is also true, but the larger numbers are coming from this cadre.

JMO,

ILT